Product Information

CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION is a generic product labeled by Cosette Pharmaceuticals, Inc., priced at $1.4209 per GM under NDC 00713084860. Its NADAC has been published 111 times since Aug 21, 2024.

FDA first approved this application on May 11, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION

calcipotriene and betamethasone dipropionate
$1.4209per GM

Strength

.5; 50 mg/g; ug/g

NDC

00713084860

Classification

Generic

Dosage Form

SUSPENSION

Route

TOPICAL

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA210765

FDA Approved

5/11/2020

TE Code

AB

On Market Since

8/2/2024

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid
Vitamin D Analog
Vitamin D

Price Statistics

The NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION has been published 111 times since Aug 21, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$1.4209 per GM
All-time high$2.4141 (Jan 14, 2026)
All-time low$1.3005 (Jun 17, 2026)
52-week high$2.4141
52-week low$1.3005
Median price$1.5088
Average price$1.6892
Largest weekly change-17.5% (Apr 22, 2026)
Weeks tracked111
Tracking sinceAug 21, 2024

Price History

1W

0.0%

1M

+0.6%

3M

+9.3%

6M

-18.1%

1Y

-30.5%

3Y

N/A

5Y

N/A

All

-1.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION?

The current National Average Drug Acquisition Cost (NADAC) for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION, manufactured by Cosette Pharmaceuticals, Inc., is $1.4209 per GM (NDC 00713084860), effective Sep 30, 2026.

How has the price of CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION changed over time?

Over the history we have for it, the NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION has held within roughly two percent of its current level. It has been tracked across 111 weekly CMS publications since Aug 21, 2024.

What are the highest and lowest recorded NADAC prices for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION?

Since Aug 21, 2024, the NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION has ranged from a low of $1.3005 (Jun 17, 2026) to a high of $2.4141 (Jan 14, 2026), with a median of $1.5088 per GM.

Are there cheaper alternatives to CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION, is $1.2133 per GM — about 15% below CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION.

Who manufactures CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION?

CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION (NDC 00713084860) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a generic product.